Heterotopic inoculation of TRPM2-AS overexpressing GBC cells resulted in a faster rate of tumor growth and significantly increased endpoint tumor weight and volume (Fig. 2A), as well as the microvascular density of resected tumors (Fig. 2C). This evidence concerns the gene TRPM2 and neoplasm.